Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation
information for practice,
Forty percent of babies who are stillborn born die after 36 weeks gestation and have no lethal structural abnormality. Maternal…